comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 00:10:23 - browse：9

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

WSS

Europe sees delivery challenges ahead on Alzheimer's therapies

AdventHealth escalates lawsuit against insurance vendor Multiplan

Feng Zhang, Grail founder join forces on new gene editing startup

Blood tests recalled over risk of missed heart attack diagnosis

The new HIV moral panic

Care demand spikes challenge UnitedHealth’s provider arm

Wikipedia

comprehensive

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Europe sees delivery challenges ahead on Alzheimer's therapies

Guidelines to prevent youth baseball injuries need more muscle

White House finalizes ITC's import ban of latest Apple Watches

State Dept. review finds Biden bears some blame for Afghanistan failures

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

In Memoriam: Notable people who died in 2023

The FDA must approve intranasal treatments for anaphylaxis

Medical leaders decry Supreme Court decision on affirmative action

How a scoliosis diagnosis changed the life of one young dancer

hotspot

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Can CDC director Mandy Cohen drive consensus in Washington?

Feng Zhang CRISPR delivery startup lays off quarter of staff

Can CDC director Mandy Cohen drive consensus in Washington?

Argenx drug significantly slows progression of nerve disorder

hotspot

explore

knowledge

leisure time